Screener
West Pharmaceutical Services WST Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 36.8%+1.5pp | 36.3%+1.7pp | 35.9%+1.4pp | 35.6%+0.7pp | 35.3%-0.4pp | |
| Operating margin | 20.5%+0.8pp | 20.3%+1.2pp | 19%-0.7pp | 19.5%-0.4pp | 19.6%-0.8pp | |
| Net margin | 17%+0.5pp | 16.8%+0.7pp | 16.1%-1.0pp | 16.3%-1.1pp | 16.5%-1.8pp | |
| Returns | ||||||
| Return on equity | 19.1%+1.4pp | 19.1%+1.7pp | 16.9%-0.9pp | 16.9%-0.8pp | 17.7%-2.0pp | |
| Return on invested capital | 19.3%+1.4pp | 19.2%+1.4pp | 17.9%-1.3pp | 17.6%-1.8pp | 17.8%-2.9pp | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | 0.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 2.8×0.0× | 2.7×-0.1× | 3×+0.2× | 2.9×-0.1× | 2.8×+0.4× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -0.1×+0.1× | -0.2×-0.1× | -0.6×-0.4× | -0.4×-0.2× | -0.3×-0.1× | |
| Per Share | ||||||
| Book value per share | $41.94+3.8% | $41.30+12.4% | $43.69+20.0% | $42.03+12.1% | $40.40+15.6% | |
| Valuation | ||||||
| Market capitalization | $24B+40.0% | $18.07B+11.6% | $19.79B-16.6% | $18.86B-13.9% | $16B-33.9% | |
| Price / earnings | 42.5×+7.3× | 33.3×-1.4× | 40.1×-8.1× | 38.4×-5.5× | 32.8×-13.3× | |
| Price / sales | 7.2×+1.4× | 5.6×0.0× | 6.4×-1.8× | 6.3×-1.4× | 5.4×-3.0× | |
| Price / book | 8×+2.2× | 6×0.0× | 6.2×-2.6× | 6.2×-1.8× | 5.5×-3.9× | |
| EV / EBITDA | 27.7×+4.9× | 21.5×-1.1× | 25.6×-6.9× | 24.6×-5.5× | 21.3×-11.7× | |
| Dividend yield | 0.3%-0.1pp | 0.3%0.0pp | 0.3%+0.1pp | 0.3%+0.1pp | 0.4%+0.1pp |
FAQ
- What are West Pharmaceutical Services's profit margins?
- West Pharmaceutical Services (WST) runs a 36.8% gross margin and a 20.5% operating margin, with a 17.0% net margin.
- Where do West Pharmaceutical Services's ratios come from?
- Every ratio is computed from West Pharmaceutical Services's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
